News Room
Taysha Gene Therapies: TSHA-102’s Potential Is A ‘Buy’ (NASDAQ:TSHA)
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is a speculative biotechnology stock aiming to potentially cure monogenic Central Nervous System (CNS) diseases…
Why the young should go to the office
Stay informed with free updatesSimply sign up to the Life & Arts myFT Digest -- delivered directly to your inbox.In…
Stocks to Watch: Block, DraftKings, Funko
By Ben Glickman Block lifted its full-year guidance for adjusted earnings after third-quarter revenue jumped. The payments company now expects…
Accenture plans mass layoffs in Detroit office due to business strategy shifts
© Reuters. Multinational consulting firm Accenture (NYSE:), known for its rich 65-year history in Michigan, is gearing up for a…
Perdoceo Education (PRDO) Continues To Fire On All Cylinders
Perdoceo Education (PRDO) had another great quarterly showing. Indeed, driven by contributions from its recent acquisitions of Coding Dojo and…
Zillow, real estate stocks fall on brokers commission verdict
Watch full video on YouTube
Darknet Drug Operations Hit as Feds Move to Seize $54 Million in Crypto Crime Bust
U.S. authorities seize over $54 million in Ethereum from darknet drug operations. Image by Bits and Splits, Adobe Stock. The…
Three Ways Business Leaders Can Drive Positive Change In Their Field
Currently the CEO of Synergy Life Science, Chris has 25 years of experience creating, distributing and supplying quality ingredients. As…